ONTX

NASDAQ:ONTX

Onconova Therapeutics, Inc.

Add to Watchlist

Stock

1.00 −0.47%

0.00

USD last updated 25/08 01:54:40

Last Close

1.00

02/04 20:00

Market Cap

20.90M

Beta: 1.77

Volume Today

1.25M

Avg: 588.32K

PE Ratio

−0.75

PFCF: −0.84

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24
revenue	800K -	11.46M 1,332%	5.55M 51.59%	787K 85.81%	1.23M 56.04%	2.18M 77.77%	231K 89.42%	226K 2.16%	226K 0%	226B 99,999,900%	226K 100.00%
cost of revenue											12K -
gross profit	800K -	11.46M 1,332%	5.55M 51.59%	787K 85.81%	1.23M 56.04%	2.18M 77.77%	231K 89.42%	226K 2.16%	226K 0%	226B 99,999,900%	214K 100.00%
selling and marketing expenses
general and administrative expenses	15.12M -	9.53M 36.95%	9.18M 3.72%	7.41M 19.32%	7.59M 2.44%	8.35M 10.01%	8.33M 0.23%	9.43M 13.20%	8.45M 10.38%	9.09T 107,659,424.09%	12.29M 100.00%
selling general and administrative expenses	15.12M -	9.53M 36.95%	9.18M 3.72%	7.41M 19.32%	7.59M 2.44%	8.35M 10.01%	8.33M 0.23%	9.43M 13.20%	8.45M 10.38%	9.09T 107,659,424.09%	12.29M 100.00%
research and development expenses	49.42M -	25.89M 47.61%	20.07M 22.49%	19.12M 4.74%	16.92M 11.48%	15.54M 8.20%	16.90M 8.76%	7.30M 56.82%	11.41M 56.31%	11.43T 100,210,315.57%	12.85M 100.00%
other expenses	-50K -	-35K 30%		30K -	1.15M 3,736.67%	143K 87.58%	48K 66.43%	12K 75%	663K 5,425%		117.46M -
cost and expenses	64.54M -	35.43M 45.11%	29.25M 17.44%	26.52M 9.32%	24.51M 7.59%	23.88M 2.56%	25.22M 5.62%	16.72M 33.71%	19.85M 18.72%	20.52T 103,379,741.84%	142.60M 100.00%
operating expenses	64.54M -	35.43M 45.11%	29.25M 17.44%	26.52M 9.32%	24.51M 7.59%	23.88M 2.56%	25.22M 5.62%	16.72M 33.71%	19.85M 18.72%	20.52T 103,379,741.84%	142.60M 100.00%
interest expense	2K -
ebitda	-63.71M -	-23.82M 62.61%	-27.66M 16.10%	-27.36M 1.06%	-24.88M 9.08%	-21.76M 12.53%	-24.79M 13.89%	-16.82M 32.15%	-19.63M 16.71%	-20.30T 103,418,659.87%	-24.90M 100.00%
operating income	-63.74M -	-23.97M 62.39%	-23.70M 1.12%	-25.74M 8.58%	-23.28M 9.54%	-21.70M 6.80%	-24.99M 15.18%	-16.50M 34.00%	-19.63M 18.98%	-20.30T 103,418,659.87%	-142.37M 100.00%
depreciation and amortization	434K -	150K 65.44%	96K 36%	88K 8.33%	55K 37.50%	-63K 214.55%	208K 430.16%	-321K 254.33%	14K 104.36%		12K -
total other income expenses net	-32K -	-35K 9.38%	4.05M 11,671.43%	1.66M 59.06%	2.75M 65.74%	206K 92.50%	-160K 177.67%	333K 308.13%	663K 99.10%	1.35T 203,619,809.50%	-24.15M 100.00%
income before tax	-63.78M -	-24.01M 62.36%	-19.65M 18.14%	-24.08M 22.52%	-20.53M 14.72%	-21.49M 4.67%	-25.15M 17.03%	-16.16M 35.74%	-18.96M 17.33%	-18.95T 99,915,529.61%	-166.52M 100.00%
income tax expense	19K -	16K 15.79%	14K 12.50%	13K 7.14%	-124K 1,053.85%	10K 108.06%	4K 60%	-335K 8,475%
net income	-63.68M -	-23.98M 62.35%	-19.67M 17.98%	-24.09M 22.50%	-20.57M 14.61%	-21.50M 4.52%	-25.16M 16.99%	-15.83M 37.08%	-18.30M 15.62%	-18.95T 103,535,225.94%	-166.52M 100.00%
weighted average shs out	9.62K -	10.11K 5.02%	19.67K 94.68%	40.00K 103.32%	274.94K 587.33%	958.97K 248.79%	11.60M 1,109.88%	16.83M 45.08%	20.91M 24.22%	20.99T 100,385,527.96%	25.31M 100.00%
weighted average shs out dil	9.62K -	10.11K 5.02%	19.67K 94.68%	40.00K 103.32%	274.94K 587.33%	958.97K 248.79%	11.60M 1,109.88%	16.83M 45.08%	20.91M 24.22%	20.99T 100,385,527.96%	25.31M 100.00%
eps	-6.62K -	-2.37K 64.15%	-999.64 57.87%	-602.28 39.75%	-74.83 87.58%	-22.42 70.04%	-2.17 90.32%	-0.94 56.68%	-0.88 6.38%	-0.90 2.27%	-6.58 631.11%
epsdiluted	-6.62K -	-2.37K 64.15%	-999.64 57.87%	-602.28 39.75%	-74.83 87.58%	-22.42 70.04%	-2.17 90.32%	-0.94 56.68%	-0.88 6.38%	-0.90 2.27%	-6.58 631.11%

All numbers in USD (except ratios and percentages)